Back

Panel discussion - Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19

28 August 2023 (17:25 - 17:30)
Organised by: Logo
Congress Presentation Part of: HOT LINE 9 Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

8 More presentations in this session

Presentation thumbnail
RIGHT: Prolongation of anticoagulation after Primary PCI
Associate Professor Y. Yan (Beijing, CN)
Slides Video
Presentation thumbnail
Discussant review - RIGHT
Professor P. Vranckx (Hasselt, BE)
Slides Video
Presentation thumbnail
Panel discussion - RIGHT
Presentation thumbnail
ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study
Doctor Y. Yamashita (Kyoto, JP)
Slides Video
Presentation thumbnail
Discussant review - ONCO DVT
Doctor T. Lopez Fernandez (Madrid, ES)
Slides Video

Access the full session

Session thumbnail
HOT LINE 9
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 17:25 CET
You may be interested in
thumbnail
Congress Presentation
Panel discussion.
27 August 2022
thumbnail
Congress Presentation
Plasma of COVID-19 positive patients promote oxidative stress and proinflammatory responses in endothelial cells: Potential role of the pro-inflammatory cytokines/SGLT2 pathway.
28 August 2022
thumbnail
Congress Presentation
Effects of SGLT2 inhibitors on the cardiovascular outcomes in patients with cancer: a systematic review and meta-analysis
1 September 2024
thumbnail
Congress Session
Cardiovascular update and COVID-19
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources